Oscar Health Stock (OSCR)

XNYS Alert Compare

Fundamental analysis

· How we analyze

Metrics from daily candles, as of Nov 20, 2026 · Extended universe

Figures in the price bar from TradingView (mostly trailing 12 months) · our fundamental analysis uses the fiscal year

Preset: moving averages 50 and 200 (on the daily chart the 50- and 200-day lines), plus volume. You can add further indicators in the chart yourself. Preset: moving averages 50 and 200 (on the daily chart the 50- and 200-day lines), plus volume. You can add further indicators in the chart yourself. Academy: 200-day line · RSI

About the company

Oscar Health is a technology-focused US health insurer. It mainly sells individual plans through the government insurance marketplaces and offers members an app with telehealth and doctor search. As of Oct 11, 2026

Fact sheet (from the annual report) Health insurance and health plans · New York, USA

Oscar offers health insurance under the ACA rules for individuals, families and employees. The plans are available in the individual market, which consists mainly of policies through insurance marketplaces, but also outside these marketplaces. Employees whose employers offer a reimbursement arrangement under the ICHRA model can also sign up for the plans. Through the +Oscar platform, the company provides healthcare providers and payers with the Campaign Builder communications platform. In 2025 Oscar acquired the enrollment platform Lucie and the broker IHC Specialty Benefits, among others.

Automatically summarized from SEC annual report (10-K, filed Feb 13, 2026) (website of the US Securities and Exchange Commission) · reviewed Oct 15, 2026

Price performance at a glance

Last 30 trading days
  • Today −5.5%
  • 7 days −20.3%
  • 30 days −26.0%
  • 1 year +89.9%
Day range (last trading day)
−0.8%Price at 9% of the range+8.2%
52-week range
−56.8%Price at 51% of the range+55.6%
Distance from the all-time high
−35.7%

Our own calculation from the exchange’s daily candles, as of Nov 20, 2026. “All-time” applies since the start of this series, not to the whole market. Changes in percent; the TradingView chart shows prices. “Today” = change of the last trading day versus the previous day. Not investment advice.

Fundamentals · Analysis method

Growth, margin, balance sheet, cash flow and dividend compared with the sector – with traffic lights and quality checks in the fundamental analysis. To the fundamental analysis

Fundamental analysis

Oscar Health · amounts in USD

Source: SEC filings, As of Feb 13, 2026.

For you first Dividend

The company pays no dividend.

For you first Valuation

There is no comparison for the P/E: the last fiscal year ended with a loss.

With a free account you can see how far – and the same for P/S and price/free cash flow, with the calculation. Sign up free

For you first Growth

How strongly revenue and earnings per share have grown over the years.

Check “Growth”
4 of 6
criteria with data met
Revenue per year (5 y)
+90.8%

For you first Quality

How much of revenue remains and whether profit arrives as cash.

Check “Quality”
0 of 7
criteria with data met
Net margin
−3.8%
Return on equity
−45.3%

For you first Trading

The overview of this stock shows the trend by timeframe.

Quality checks

Four angles on the annual figures. Each check counts how many disclosed criteria are met – criteria without data do not count. The bars show where the company ranks on each figure among the stocks we cover and within its sector.

Fiscal year to Dec 31, 2025

Quality 0 of 7 met · 1 without data

  • no data: Gross margin above 40% not stated in the SEC filings
  • not met: Operating margin above 15% −3.4%
  • not met: Net margin above 10% −3.8%
  • not met: Return on equity above 15% −45.3%
  • not met: Free cash flow margin above 10% 9.0%
  • not met: Profit in each of the last 5 fiscal years 1 of 5
  • not met: Free cash flow positive in each of the last 3 fiscal years 2 of 3
  • not met: Equity ratio above 30% 15.5%
Operating margin

−3.4% Fiscal year 2025

Rank 13 of 100: higher than 13% of 470 peers (All). weak.

Operating income divided by revenue: what the core business earns before interest and taxes.

Net margin

−3.8% Fiscal year 2025

Rank 10 of 100: higher than 10% of 584 peers (All). weak.

Profit after all costs, interest and taxes divided by revenue.

Return on equity

−45.3% Fiscal year 2025

Rank 3 of 100: higher than 3% of 544 peers (All). weak.

Net income divided by equity at fiscal year end.

Return on assets

−7.0% Fiscal year 2025 (total assets at year end)

Rank 7 of 100: higher than 7% of 594 peers (All). weak.

Net income divided by total assets at fiscal year end.

Equity ratio

15.5% Fiscal year 2025

Rank 19 of 100: higher than 19% of 595 peers (All). weak.

Equity as a share of total assets. Usually low for banks.

Free cash flow margin

9.0% Fiscal year 2025

Rank 43 of 100: higher than 43% of 465 peers (All). medium.

Free cash flow divided by revenue.

Free cash flow

1.1B USD Fiscal year 2025

Operating cash flow minus capital expenditure on property and equipment.

Growth 4 of 6 met · 1 without data

  • met: Over 3 years, revenue grew by more than 5% per year +43.5%
  • met: Over 5 years, revenue grew by more than 5% per year +90.8%
  • no data: Over 10 years, revenue grew by more than 5% per year no comparable figures over 10 years
  • not met: Over 3 years, EPS grew by more than 5% per year no earnings per share in the last fiscal year
  • not met: Over 5 years, EPS grew by more than 5% per year no earnings per share in the last fiscal year
  • met: Revenue rose in at least 4 of the last 5 fiscal years 5 of 5
  • met: Revenue rose in the last fiscal year +27.5%
Revenue growth 3 years

+43.5% per year

Rank 95 of 100: higher than 95% of 578 peers (All). strong.

Average growth per year over 3 fiscal years.

Revenue growth 5 years

+90.8% per year

Rank 99 of 100: higher than 99% of 549 peers (All). strong.

Average growth per year over 5 fiscal years.

Dividend 0 of 1 met · 6 without data

  • not met: Pays a dividend no dividend per share reported for the last fiscal year
  • no data: Payout ratio at most 60% of earnings pays no dividend
  • no data: Dividend paid in each of the last 5 fiscal years pays no dividend
  • no data: Dividend per share never lowered in the last 5 fiscal years pays no dividend
  • no data: Dividend per share higher than 5 years ago pays no dividend
  • no data: Free cash flow per share covers the dividend pays no dividend
  • no data: Dividends paid over the last 5 years covered by free cash flow pays no dividend

Financial strength 3 of 5 met · 1 without data

  • not met: Piotroski F-Score at least 7 of 9 4 of 8 · 1 without data
  • met: Long-term debt no higher than equity 0.44
  • not met: Current assets cover current liabilities 0.95
  • met: Positive equity 977.6M USD
  • no data: In 5 years, share count up by at most 5% no comparable share count 5 years ago
  • met: Free cash flow positive in the last fiscal year 1.1B USD
Piotroski F-Score

4 of 8 Fiscal year 2025

No rank: not all 9 criteria have data.

Nine yes/no tests on profit, cash flow, debt, liquidity and efficiency compared with the prior year.

Debt / equity

0.44 at fiscal year end

Rank 67 of 100: lower than 67% of 486 peers (All). strong.

Long-term financial debt divided by equity.

Liquidity (current ratio)

0.95 at fiscal year end

Rank 23 of 100: higher than 23% of 513 peers (All). weak.

Current assets divided by current liabilities.

Change in share count

+23.5% in 3 years

No rank: too few peers or not computed yet.

Change in diluted share count. Negative = share buybacks, positive = new shares.

The 9 criteria of the Piotroski F-Score
  • not met: Profit in the last fiscal year (positive return on assets)
  • met: Positive operating cash flow
  • not met: Return on assets higher than the prior year
  • met: Operating cash flow higher than net income
  • not met: Long-term debt relative to total assets fell
  • met: Liquidity (current assets / current liabilities) rose
  • met: No additional shares (diluted share count did not rise)
  • no data: Gross margin higher than the prior year
  • not met: Revenue relative to total assets higher than the prior year

Last fiscal year compared with the one before. Returns and revenue per total assets use total assets at the start of the year; leverage = long-term financial debt divided by total assets at year end; new shares via the average diluted share count.

Price-based criteria (P/E, dividend yield) are shown to signed-in users.

Computed automatically from SEC annual reports – not investment advice. Describes the reported figures; points are not a rating of the stock. Rank 0–100 against the 239 stocks we cover and against the sector (from 5 peers); the stronger side is always on the right.

In short

  • Light green: Revenue grew over 5 years (+90.8% per year).
  • Light red: Loss in the last fiscal year.
  • Light red: Profit in 1 of 7 fiscal years.

Summarized from the lights below. Describes the reported figures – not a recommendation to buy or sell.

RevenueNet income Net margin (below) in USD
  1. Fiscal year 2019 (Jan 1, 2019 – Dec 31, 2019): Revenue 488.2M USD · Net income −261.2M USD · Net margin −53.5%
  2. Fiscal year 2020 (Jan 1, 2020 – Dec 31, 2020): Revenue 462.8M USD · Net income −406.8M USD · Net margin −87.9%
  3. Fiscal year 2021 (Jan 1, 2021 – Dec 31, 2021): Revenue 1.8B USD · Net income −572.6M USD · Net margin −31.1%
  4. Fiscal year 2022 (Jan 1, 2022 – Dec 31, 2022): Revenue 4.0B USD · Net income −606.3M USD · Net margin −15.3%
  5. Fiscal year 2023 (Jan 1, 2023 – Dec 31, 2023): Revenue 5.9B USD · Net income −270.7M USD · Net margin −4.6%
  6. Fiscal year 2024 (Jan 1, 2024 – Dec 31, 2024): Revenue 9.2B USD · Net income 25.4M USD · Net margin 0.3%
  7. Fiscal year 2025 (Jan 1, 2025 – Dec 31, 2025): Revenue 11.7B USD · Net income −443.2M USD · Net margin −3.8%

Fiscal year 2025 (Jan 1, 2025 – Dec 31, 2025): Revenue 11.7B USD · Net income −443.2M USD · Net margin −3.8%

How has it gone since the last annual report?

Trailing 12 months and quarters

Revenue in the quarter to Sep 2026 +72.1% vs. the same quarter a year earlier; grown for at least 16 quarters in a row.

Revenue 12 months vs. prior 12
+54.8%
12 months: 17.5B USD · Fiscal year 2025: +27.5%
Net margin 12 months
4.9%
Fiscal year 2025: −3.8%
Free cash flow margin 12 months
23.7%
Fiscal year 2025: 9.0%
More depth

Calculation of the 12 months to Sep 30, 2026

  • Revenue: fiscal year to Dec 31, 2025 11.7B USD + year to date to Sep 30, 2026 14.7B USD − same period a year earlier to Sep 30, 2025 8.9B USD = 17.5B USD
  • Net income: fiscal year to Dec 31, 2025 −443.2M USD + year to date to Sep 30, 2026 1.2B USD − same period a year earlier to Sep 30, 2025 −90.5M USD = 855.5M USD
  • Operating cash flow: fiscal year to Dec 31, 2025 1.1B USD + year to date to Sep 30, 2026 3.5B USD − same period a year earlier to Sep 30, 2025 423.0M USD = 4.2B USD
  • Capital expenditure: fiscal year to Dec 31, 2025 36.4M USD + year to date to Sep 30, 2026 31.9M USD − same period a year earlier to Sep 30, 2025 27.3M USD = 40.9M USD
By quarter (latest first, amounts in USD)
QuarterRevenuevs. year agoNet incomeMargin
Jul–Sep 265.1B+72.1%167.3M3.3%
Apr–Jun 264.9B+70.4%361.8M7.4%
Jan–Mar 264.6B+52.6%679.0M14.6%
Oct–Dec 25*2.8B+17.3%−352.6M−12.6%
Jul–Sep 253.0B+23.2%−137.5M−4.6%
Apr–Jun 252.9B+29.0%−228.4M−8.0%
Jan–Mar 253.0B+42.2%275.3M9.0%
Oct–Dec 24*2.4B+67.1%−153.5M−6.4%

Trailing 12 months = last fiscal year + the period since the start of the current fiscal year − the same period a year earlier, each from the first filing. P/E, PEG and the quality checks still use the last fiscal year.

Each quarter is compared with the same quarter a year earlier.

* derived: fiscal year minus the first 9 months.

As of: 12 months to Sep 30, 2026, filed on Nov 5, 2026 · Source: SEC filings (10-Q, 10-K)

Does the profit arrive as cash?

Earnings quality

There was no profit in fiscal year 2025; operating income does not cover interest.

Cash flow ÷ profit
–
no profit in fiscal year 2025
Interest coverage
negative
operating income negative · 3 years: negative
Tax rate
–
no profit before tax
More depth

Calculation for fiscal year 2025

  • Operating cash flow 1.1B USD ÷ group profit incl. minority interests −442.9M USD = no ratio (no profit)
  • Operating income −396.4M USD ÷ Interest expense 17.6M USD = negative
  • Taxes 5.6M USD ÷ profit before tax −437.3M USD = no rate (no profit before tax)
By fiscal year
FYCash flow ÷ profitInterest coverageTax rate
2025–negative–
2024over 10x2.4x21.9%
2023–negative–
2022–negative–
2021–negative–

How it is rated: cash flow ÷ profit from 1.0 “backed by cash”, below 0.8 “profit well above the cash coming in”; interest coverage from 5 “well covered”, below 2 “thinly covered”. The tax rate is only shown.

Cash flow ÷ profit uses group profit incl. minority interests, because cash flow also covers the whole group. Profit before tax as reported to the SEC, otherwise approximated. “3 years” = sums of the last three fiscal years – only if every year is reported and the figures have the same origin; for cash flow only with a profit in every year.

As of fiscal year 2025 · Source: SEC filings

How even were the last years?

Consistency

In 7 fiscal years 6 loss years; one year with lower revenue across 6 years with a prior-year figure.

Loss years
6 of 7
net income below zero
Years with lower revenue
1 of 6
revenue below the prior year
Net margin range
88.2 percentage points
from −87.9% to 0.3%
Net margin by fiscal year · ▾ revenue below the prior year
More depth
By fiscal year
FYRevenue vs. prior yearNet margin
2025+27.5%−3.8%
2024+56.5%0.3%
2023+47.9%−4.6%
2022+115.6%−15.3%
2021+297.3%−31.1%
2020−5.2%−87.9%
2019–−53.5%

Loss year: net income below zero. Lower revenue: revenue below the prior year. Range: highest minus lowest net margin; margins beyond ±200% do not count. No score – only the reported figures.

As of fiscal years 2019–2025 · Source: SEC filings

Figures over time

Where the money of a fiscal year goes and how margins, returns, balance sheet, cash flow and share count developed over up to 10 years. Each chart has one sentence saying what the trend shows.

Money flow in fiscal year 2025

Of 100 USD of revenue, no profit was left.

Operating loss: −3.4% of revenue

Money flow as a table
Fiscal year 2025, amounts in USD, share of revenue
ItemAmountof revenue
Revenue11.7B USD100.0%
Cost of revenue and operating expenses12.1B USD103.4%

Taxes, interest and other items are not available separately in the SEC data; they are combined as the difference.

Margins

The operating margin rose in 5 years from −86.9% to −3.4%.

Operating marginNet margin
  1. Fiscal year 2019: Operating margin −53.1% · Net margin −53.5%
  2. Fiscal year 2020: Operating margin −86.9% · Net margin −87.9%
  3. Fiscal year 2021: Operating margin −29.6% · Net margin −31.1%
  4. Fiscal year 2022: Operating margin −14.9% · Net margin −15.3%
  5. Fiscal year 2023: Operating margin −4.0% · Net margin −4.6%
  6. Fiscal year 2024: Operating margin 0.6% · Net margin 0.3%
  7. Fiscal year 2025: Operating margin −3.4% · Net margin −3.8%

Returns

Return on equity fell in 4 years from −41.3% to −45.3%.

Return on equityReturn on assets
  1. Fiscal year 2019: Return on equity not available · Return on assets not available
  2. Fiscal year 2020: Return on equity not available · Return on assets −17.9%
  3. Fiscal year 2021: Return on equity −41.3% · Return on assets −17.2%
  4. Fiscal year 2022: Return on equity −68.1% · Return on assets −13.4%
  5. Fiscal year 2023: Return on equity −33.7% · Return on assets −7.5%
  6. Fiscal year 2024: Return on equity 2.5% · Return on assets 0.5%
  7. Fiscal year 2025: Return on equity −45.3% · Return on assets −7.0%

Equity and long-term debt

The equity ratio rose in 5 years from −57.0% to 15.5%.

EquityLong-term debt in USD Long-term debt, depending on the filing, includes the current portion or leases.
  1. Fiscal year 2019: Equity −945.1M USD · Long-term debt not available
  2. Fiscal year 2020: Equity −1.3B USD · Long-term debt 142.5M USD
  3. Fiscal year 2021: Equity 1.4B USD · Long-term debt 0.0 USD
  4. Fiscal year 2022: Equity 890.4M USD · Long-term debt 298.0M USD
  5. Fiscal year 2023: Equity 804.0M USD · Long-term debt 298.8M USD
  6. Fiscal year 2024: Equity 1.0B USD · Long-term debt 299.6M USD
  7. Fiscal year 2025: Equity 977.6M USD · Long-term debt 430.1M USD

Liquidity (current ratio)

The current ratio fell in 5 years from 1.12 to 0.95.

Current ratio
  1. Fiscal year 2019: Current ratio not available
  2. Fiscal year 2020: Current ratio 1.12
  3. Fiscal year 2021: Current ratio 1.24
  4. Fiscal year 2022: Current ratio 1.26
  5. Fiscal year 2023: Current ratio 1.26
  6. Fiscal year 2024: Current ratio 0.82
  7. Fiscal year 2025: Current ratio 0.95

Cash flow

Free cash flow rose in 5 years from 208.7M USD to 1.1B USD.

Operating cash flowCapital expenditureFree cash flow in USD
  1. Fiscal year 2019: Operating cash flow −165.4M USD · Capital expenditure 26.0M USD · Free cash flow −191.4M USD
  2. Fiscal year 2020: Operating cash flow 222.7M USD · Capital expenditure 14.0M USD · Free cash flow 208.7M USD
  3. Fiscal year 2021: Operating cash flow −181.7M USD · Capital expenditure 25.9M USD · Free cash flow −207.6M USD
  4. Fiscal year 2022: Operating cash flow 380.3M USD · Capital expenditure 29.0M USD · Free cash flow 351.3M USD
  5. Fiscal year 2023: Operating cash flow −272.2M USD · Capital expenditure 25.6M USD · Free cash flow −297.7M USD
  6. Fiscal year 2024: Operating cash flow 978.2M USD · Capital expenditure 27.9M USD · Free cash flow 950.3M USD
  7. Fiscal year 2025: Operating cash flow 1.1B USD · Capital expenditure 36.4M USD · Free cash flow 1.1B USD

Share count

The share count rose in 4 years by 46.6% – more new shares were issued than repurchased (dilution).

Diluted share count
  1. Fiscal year 2019: Diluted share count 28.8M
  2. Fiscal year 2020: Diluted share count 29.3M
  3. Fiscal year 2021: Diluted share count 179.0M
  4. Fiscal year 2022: Diluted share count 212.5M
  5. Fiscal year 2023: Diluted share count 221.7M
  6. Fiscal year 2024: Diluted share count 265.9M
  7. Fiscal year 2025: Diluted share count 262.4M

From annual reports filed with the SEC (10-K, 20-F, 40-F) as first reported, share count adjusted for splits; obvious filing errors (e.g. wrong unit, outliers against both neighbouring years) are hidden. Describes the reported figures – not investment advice.

Metrics chart

Up to three metrics stacked over the same fiscal years – so you see at a glance whether they rise together or drift apart. Point at a year to read it in every panel.

Metrics, up to 3 – to switch, deselect one first

Premium Line of a second stock for comparison

Revenue

Revenue rose in 5 years from 462.8M USD to 11.7B USD.

OSCR in USD
  1. Fiscal year 2019: OSCR 488.2M USD
  2. Fiscal year 2020: OSCR 462.8M USD
  3. Fiscal year 2021: OSCR 1.8B USD
  4. Fiscal year 2022: OSCR 4.0B USD
  5. Fiscal year 2023: OSCR 5.9B USD
  6. Fiscal year 2024: OSCR 9.2B USD
  7. Fiscal year 2025: OSCR 11.7B USD

Net margin

The net margin rose in 5 years from −87.9% to −3.8%.

OSCR
  1. Fiscal year 2019: OSCR −53.5%
  2. Fiscal year 2020: OSCR −87.9%
  3. Fiscal year 2021: OSCR −31.1%
  4. Fiscal year 2022: OSCR −15.3%
  5. Fiscal year 2023: OSCR −4.6%
  6. Fiscal year 2024: OSCR 0.3%
  7. Fiscal year 2025: OSCR −3.8%

Free cash flow margin

The free cash flow margin fell in 5 years from 45.1% to 9.0%.

OSCR
  1. Fiscal year 2019: OSCR −39.2%
  2. Fiscal year 2020: OSCR 45.1%
  3. Fiscal year 2021: OSCR −11.3%
  4. Fiscal year 2022: OSCR 8.9%
  5. Fiscal year 2023: OSCR −5.1%
  6. Fiscal year 2024: OSCR 10.4%
  7. Fiscal year 2025: OSCR 9.0%

Source: SEC filings, fiscal years up to Dec 31, 2025. The same figures as in the sections of this page, per fiscal year as first reported. Describes the reported figures – not investment advice.

How reliable is the dividend?

Dividend at a glance

The company pays no dividend.

As of fiscal year 2025 · Source: SEC filings

Valued higher or lower than usual?

Valuation against its own history

There is no comparison for the P/E: the last fiscal year ended with a loss.

With a free account you can see how far – and the same for P/S and price/free cash flow, with the calculation. Sign up free

Source: SEC filings and our daily candles

Dividends and share repurchases

How much the company returns to its shareholders – as dividends or by repurchasing its own shares – and whether free cash flow supports it.

Dividend per share
none pays no dividend

What goes back to shareholders

Dividends paidShare repurchasesNew shares issued (including employee plans)Free cash flow in USD
  1. Fiscal year 2019: Dividends paid not available · Share repurchases 3.0M USD · New shares issued (including employee plans) not available · Free cash flow −191.4M USD
  2. Fiscal year 2020: Dividends paid not available · Share repurchases 0.0 USD · New shares issued (including employee plans) not available · Free cash flow 208.7M USD
  3. Fiscal year 2021: Dividends paid not available · Share repurchases 0.0 USD · New shares issued (including employee plans) not available · Free cash flow −207.6M USD
  4. Fiscal year 2022: Dividends paid not available · Share repurchases not available · New shares issued (including employee plans) not available · Free cash flow 351.3M USD
  5. Fiscal year 2023: Dividends paid not available · Share repurchases not available · New shares issued (including employee plans) not available · Free cash flow −297.7M USD
  6. Fiscal year 2024: Dividends paid not available · Share repurchases not available · New shares issued (including employee plans) not available · Free cash flow 950.3M USD
  7. Fiscal year 2025: Dividends paid not available · Share repurchases not available · New shares issued (including employee plans) not available · Free cash flow 1.1B USD

Dividends paid, repurchases and new shares issued from the cash flow statement of annual reports filed with the SEC (as first reported). Describes the reported figures – not investment advice.

Valuation over time

Price-based valuation (P/E, P/S, price/free cash flow and dividend yield per fiscal year, compared with its own average) for signed-in users.

Key figures with traffic lights

Each light follows a simple, disclosed rule. This symbol has no sector assignment – lights with a sector comparison stay gray or use only the basic rule.

Revenue growth

Light green: growing

+90.8% per year, last 5 years

What does this mean? Revenue: over 5 years it grew by 90.8% per year on average. Comparable values for a sector comparison are missing.

Light rule: Green: grows at least as fast as the sector median (without a sector comparison: grows) · Yellow: grows more slowly · Red: shrinks.

Net income (total)

Light gray: not computable

– per year, last 5 years

per share: not computable (loss in the first or last year)

What does this mean? There was a loss in the first or last year. An annual growth rate cannot be calculated meaningfully then.

Light rule: Green: grows at least as fast as the sector median (without a sector comparison: grows) · Yellow: grows more slowly · Red: shrinks.

Net margin

Light red: Loss

−3.8% last fiscal year

What does this mean? Of every 100 USD in revenue there was no profit but a loss of 3.79 USD. Five years ago the margin was −87.9%.

Light rule: Green: at least the sector median (without a sector comparison: profit) · Yellow: profit, but below the median · Red: loss.

Debt / equity

Light gray: no comparison

0.19 latest balance sheet

What does this mean? For every 1 USD of equity there is 0.19 USD of financial debt. Without a sector comparison this is hard to put into context.

Light rule: Green: at most the sector median · Yellow: up to twice the median · Red: more than twice · Gray: without a sector comparison.

Payout ratio

Light gray: none found

– Dividend / earnings per share

What does this mean? The loaded SEC filings of the last two fiscal years contain no dividend per share. Either the company pays none, or it reports it under a different tag.

Light rule: Green: up to 60% of earnings · Yellow: up to 100% · Red: more than earnings or a dividend despite a loss · Gray for real estate (REITs). The sector median is for comparison only.

Profitable years

Light red: 6 loss years

1 of 7 fiscal years with a profit

What does this mean? In 1 of the last 7 fiscal years the bottom line showed a profit. 6 years ended with a loss.

Light rule: Green: profit in every year · Yellow: one loss year · Red: several loss years (at least 3 years needed).

Last fiscal year and 13F

Information, not a trading signal · Source: SEC EDGAR
Revenue (FY)
11.7B USD
Revenue vs. prior year
+27.5%
Net income (FY)
−443.2M USD
Net income vs. prior year
−1,842.5%
EPS (FY)
-1.69 USD
Superinvestors holding
3 of 26
Fiscal year to Dec 31, 2025 · 10-K filed Feb 13, 2026 · Balance sheet Sep 30, 2026 (filed Nov 5, 2026) · Price-based figures (P/E, P/S, dividend yield, market cap) only when logged in. · Values as first reported; debt = reported financial debt (US GAAP: long-term). Superinvestors: 26 tracked investors per 13F filing (as of quarter end, filed up to 45 days later); weight and change per investor in the card “Which superinvestors hold …?”.
All figures as a table
Fiscal years (amounts in USD, per share in USD)
YearEndRevenueNet income MarginEarnings per shareDividend per sharePayout
2025Dec 31, 2025 11.7B−443.2M −3.8% −1.69 – –
2024Dec 31, 2024 9.2B25.4M 0.3% 0.10 – –
2023Dec 31, 2023 5.9B−270.7M −4.6% −1.22 – –
2022Dec 31, 2022 4.0B−606.3M −15.3% −2.85 – –
2021Dec 31, 2021 1.8B−572.6M −31.1% −3.20 – –
2020Dec 31, 2020 462.8M−406.8M −87.9% −14.16 – –
2019Dec 31, 2019 488.2M−261.2M −53.5% −9.06 – –
Quarters (amounts in USD, per share in USD)
QuarterEndRevenueNet income MarginEarnings per shareDividend per sharePayout
Q3/26Sep 30, 2026 5.1B167.3M 3.3% 0.49 – –
Q2/26Jun 30, 2026 4.9B361.8M 7.4% 1.10 – –
Q1/26Mar 31, 2026 4.6B679.0M 14.6% 2.07 – –
Q4/25*Dec 31, 2025 2.8B−352.6M −12.6% – – –
Q3/25Sep 30, 2025 3.0B−137.5M −4.6% −0.53 – –
Q2/25Jun 30, 2025 2.9B−228.4M −8.0% −0.89 – –
Q1/25Mar 31, 2025 3.0B275.3M 9.0% 0.92 – –
Q4/24*Dec 31, 2024 2.4B−153.5M −6.4% – – –
Q3/24Sep 30, 2024 2.4B−54.6M −2.3% −0.22 – –
Q2/24Jun 30, 2024 2.2B56.2M 2.5% 0.20 – –
Q1/24Mar 31, 2024 2.1B177.4M 8.3% 0.62 – –
Q4/23*Dec 31, 2023 1.4B−150.0M −10.5% – – –

* Q4 derived: fiscal year minus the 9-month value (EPS cannot be derived this way); may be distorted by restatements.

How we calculate: values as first reported to the SEC (later corrections are left out), a fixed order of reporting tags per figure, partial sums are never added up. Growth per year over 5 years (otherwise 3 years). Quarters are labeled by the calendar quarter in which they end.

Information only – does not affect the other analysis methods, not investment advice.

Insiders

All insider transactions
Insider purchases and sales on the market over 3, 6 and 12 months
PeriodPurchasesSalesNet
3 months $00 people $26.2M6 people −$26.2M
6 months $00 people $131.1M7 people −$131.1M
12 months $11.9M1 person $144.1M7 people −$132.1M

Latest transactions

  • Sep 18, 2026 Wittman Vanessa Ames Director Open-market sale · 10b5-1 plan 25,000 shares · $806.0K · SEC
  • Sep 3, 2026 Baltrus Victoria Officer Open-market sale · 10b5-1 plan 958 shares · $30.1K · SEC
  • Sep 3, 2026 Schlosser Mario Director Open-market sale · 10b5-1 plan 31,422 shares · $988.2K · SEC
  • Sep 3, 2026 McAnaney Adam Officer Open-market sale · 10b5-1 plan 9,092 shares · $285.9K · SEC
  • Sep 3, 2026 Liang Janet Officer Open-market sale · 10b5-1 plan 10,360 shares · $325.8K · SEC
  • Sep 3, 2026 Blackley Richard Scott Chief financial officer (CFO) Open-market sale · 10b5-1 plan 28,869 shares · $907.9K · SEC

Source: mandatory filings with the SEC (Form 4), open-market purchases and sales only. General information, not investment advice.

Which superinvestors hold Oscar Health?

All superinvestor portfolios

3 of 26 tracked superinvestors report a position.

Superinvestors with a position in Oscar Health, weight in each portfolio
InvestorWeight in portfoliovs. previous quarterAs of
Renaissance Technologies 0.2% +17.2% increased Q3 2026
Bridgewater Associates 0.2% +423.2% increased Q3 2026
Steve Cohen Point72 Asset Management < 0.1% +17.0% increased Q3 2026

Sold out in the latest quarter: Paul Tudor Jones.

Source: 13F filing with the US Securities and Exchange Commission, latest filing dated Nov 16, 2026. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

Trend score –

We do not calculate a trend score for symbols in the extended universe.

Volatility and trend strength

ADX 14 (trend strength)–
Price change 60 days–

ATR and moving averages as price values only when logged in.

More stocks from Other stocks

All symbols in this sector

News

No recent news found. News is loaded automatically three times a day for trend stocks, symbols with a current Elliott setup and favorites.

Posts

No posts on OSCR yet – log in to join the discussion.

Posts are opinions of users and only visible after logging in. Community rules

Set alert: OSCR

Alerts with a free account: we send you an email as soon as the price moves above or below your level.

Checked after every data update: crypto hourly, stocks twice a day, precious metals every 4 hours on trading days, extended universe on weekdays after the close (daily candles) – not in real time.

↑ ↓ select · Enter open · Esc close